Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Innocenti

Showing results (161-170 of 186) with videos related to

Pageof 19
Sort By:
Clinical Chemistry and Laboratory Medicine|November 1, 2017
A transnational collaborative network dedicated to the study and applications of the vascular endothelial growth factor-A in medical practice: the VEGF ConsortiumMaria G Stathopoulou, Ting Xie, Daniela Ruggiero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2018
Identification of a Genomic Region between <i>SLC29A1</i> and <i>HSP90AB1</i> Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance)Megan Li, Flora Mulkey, Chen Jiang, et al.
American Journal of Human Genetics|May 26, 2021
Genetic effects on liver chromatin accessibility identify disease regulatory variantsKevin W Currin, Michael R Erdos, Narisu Narisu, et al.
Journal of the National Cancer Institute|October 12, 2021
Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405Marla Lipsyc-Sharf, Sui Zhang, Fang-Shu Ou, et al.
British Journal of Cancer|December 2, 2021
Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patientsJulia C F Quintanilha, Jin Wang, Alexander B Sibley, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2025
Outcomes for FOLFIRI plus bevacizumab or cetuximab in patients treated with oxaliplatin-based adjuvant therapy: A combined analysis of FIRE-3 and CALGB/SWOG 80405 (Alliance)Francesca Battaglin, Bert H O'Neil, Sebastian Stintzing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2019
Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405Brendan J Guercio, Sui Zhang, Fang-Shu Ou, et al.
JNCI Cancer Spectrum|November 2, 2020
Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405Brendan J Guercio, Sui Zhang, Alan P Venook, et al.
British Journal of Cancer|October 7, 2021
Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patientsJulia C F Quintanilha, Jin Wang, Alexander B Sibley, et al.
Research Square|January 3, 2024
Gene signatures derived from transcriptomic-causal networks stratified colorectal cancer patients for effective targeted therapyAkram Yazdani, Heinz-Josef Lenz, Gianluigi Pillonetto, et al.
Pageof 19

Showing results (161-170 of 186) with videos related to

Sort By:
Pageof 19
Clinical Chemistry and Laboratory Medicine|November 1, 2017
A transnational collaborative network dedicated to the study and applications of the vascular endothelial growth factor-A in medical practice: the VEGF ConsortiumMaria G Stathopoulou, Ting Xie, Daniela Ruggiero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2018
Identification of a Genomic Region between <i>SLC29A1</i> and <i>HSP90AB1</i> Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance)Megan Li, Flora Mulkey, Chen Jiang, et al.
American Journal of Human Genetics|May 26, 2021
Genetic effects on liver chromatin accessibility identify disease regulatory variantsKevin W Currin, Michael R Erdos, Narisu Narisu, et al.
Journal of the National Cancer Institute|October 12, 2021
Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405Marla Lipsyc-Sharf, Sui Zhang, Fang-Shu Ou, et al.
British Journal of Cancer|December 2, 2021
Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patientsJulia C F Quintanilha, Jin Wang, Alexander B Sibley, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2025
Outcomes for FOLFIRI plus bevacizumab or cetuximab in patients treated with oxaliplatin-based adjuvant therapy: A combined analysis of FIRE-3 and CALGB/SWOG 80405 (Alliance)Francesca Battaglin, Bert H O'Neil, Sebastian Stintzing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2019
Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405Brendan J Guercio, Sui Zhang, Fang-Shu Ou, et al.
JNCI Cancer Spectrum|November 2, 2020
Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405Brendan J Guercio, Sui Zhang, Alan P Venook, et al.
British Journal of Cancer|October 7, 2021
Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patientsJulia C F Quintanilha, Jin Wang, Alexander B Sibley, et al.
Research Square|January 3, 2024
Gene signatures derived from transcriptomic-causal networks stratified colorectal cancer patients for effective targeted therapyAkram Yazdani, Heinz-Josef Lenz, Gianluigi Pillonetto, et al.
Pageof 19